Menlo Ventures leads $100M round in Nourish to give every GLP-1 patient a dietitian as weight loss drugs take off — TFN

Nourish raised $100M in a Series C round led by Menlo Ventures, taking its total funding to $215M and valuing the company at $1.75 billion.

The metabolic health startup combines Registered Dietitians with AI-powered care agents to tackle chronic disease and improve long-term outcomes.

Nourish now works with more than 10,000 dietitians and serves patients across all 50 US states through major health plan partnerships.

As healthcare systems struggle with rising obesity, diabetes, and cardiovascular disease rates, Nourish has secured $100 million in Series C funding to scale its nutrition-first care platform. The round was led by Menlo Ventures, with backing from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners. This round brings the total funding to $215 million and values the company at $1.75 billion.

Founded in 2021 in New York by Aidan Dewar, Sam Perkins, and Stephanie Liu, Nourish has rapidly become the largest dietitian-led metabolic health clinic in the US. The company focuses on reversing chronic disease through a virtual care model that pairs human specialists with intelligent software designed to support behaviour change, care coordination, and long-term patient engagement.